Chapter 23 Flashcards

1
Q

Description and etiology
Patho
Assessment and dx
Medical management
Nursing management

A

Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Normal consciousness requires awareness and arousal.
Awareness is the combination of cognition (mental and intellectual) and affect (mood) that can be construed based on the patient’s interaction with the environment. Alterations of consciousness may be the result of deficits in awareness, arousal, or both.
Coma is characterized by the absence of both wakefulness and awareness, Coma is the deepest state of unconsciousness; arousal and awareness are lacking. The patient cannot be aroused and does not demonstrate any purposeful response to the surrounding environment. Coma is a symptom rather than a disease, and it occurs as a result of some underlying process.
causes of coma can be divided into two general categories: structural or surgical and metabolic or medical.
Structural causes of coma include ischemic stroke, ICH, trauma, and brain tumors. Metabolic causes of coma include drug overdose, infectious diseases, endocrine disorders, and poisonings. The three most common causes of nontraumatic coma are stroke, anoxia, and poisonings. Coma demands immediate attention, resulting in a high percentage of admissions to all hospital services.

A

Description and etiology - Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Consciousness involves arousal, or wakefulness, and awareness.
Neither of these functions is present in a patient in coma.
Structural causes usually produce compression or dysfunction in the area of the ascending reticular activating system (RAS), whereas most medical causes lead to general dysfunction of both cerebral hemispheres. Trauma, hemorrhage, and tumor can damage the ascending RAS, leading to coma. Destruction of large regions of bilateral cerebral hemispheres can be the result of seizures or viral agents. Toxic drugs, toxins, or metabolic abnormalities can suppress cerebral function.

A

Patho - Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Structural causes usually produce compression or dysfunction in the area of the ascending RAS, whereas most medical causes lead to general dysfunction of both cerebral hemispheres. Trauma, hemorrhage, and tumor can damage the ascending RAS, leading to coma. Destruction of large regions of bilateral cerebral hemispheres can be the result of seizures or viral agents. Toxic drugs, toxins, or metabolic abnormalities can suppress cerebral function.
Medical history is essential,Detailed serial neurologic examinations are essential for all patients in coma.
Assessment of pupillary size and reaction to light (normal, sluggish, or fixed), extraocular eye movements (normal, asymmetric, or absent), motor response to pain (normal, decorticate, decerebrate, or flaccid), and breathing pattern yields important clues for determining whether the cause of coma is structural or metabolic.
Deficits in extraocular eye movements usually accompany a structural cause.
Focal or asymmetric motor deficits usually indicate structural lesions.
Abnormal breathing patterns may also assist in differentiating structural from metabolic causes of coma. Cheyne Stokes respirations are seen in patients with cerebral hemispheric dysfunction or metabolic suppression. Central neurogenic hyperventilation, or Kussmaul breathing, occurs with metabolic acidosis or damage to the midbrain and upper pons. Apneustic breathing may occur with damage to the pons, hypoglycemia, and anoxia. Ataxic breathing occurs with damage to the medulla. Agonal breathing occurs with failure of the respiratory centers in the medulla.
laboratory studies and diagnostic procedures are done.
Structural causes of coma are usually readily apparent with CT or MRI. Laboratory studies are also used to identify metabolic or endocrine abnormalities.
An electroencephalogram should be obtained to search for sleep patterns, particularly rapid eye movement sleep and slow-wave sleep. A positron emission tomography scan may also be helpful in detecting consciousness.

A

Assessment and dx - Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

is identification and treatment of the underlying cause of the condition.
Initial medical management includes emergency measures to support vital functions and prevent further neurologic deterioration. Protection of the airway and ventilatory assistance are often needed. Administration of thiamine
Intubation for continued airway protection and nutrition support is essential. Fluid and electrolyte management is often complex because of alterations in the neurohormonal system. Anticonvulsant therapy may be necessary to prevent further ischemic damage to the brain.
Prognosis depends on the cause of coma and the length of time unconsciousness persists.

A

Medical management - Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A patient care management plan for a patient in coma incorporates a variety of patient problems and is directed by the specific cause of coma, although some common interventions are used.
a significant role in monitoring for changes in neurologic status and clues to the origin of coma, supporting all body functions, maintaining surveillance for complications, providing comfort and emotional support, and initiating rehabilitation measures. Measures to support body functions include promoting pulmonary hygiene, maintaining skin integrity, initiating range-of-motion exercises, managing bowel and bladder functions, and ensuring adequate nutrition support.

A

Nursing management - Coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A craniotomy is performed to gain access to portions of the central nervous system (CNS) inside the cranium, usually to allow removal of a space-occupying lesion
Common procedures include tumor resection or removal, cerebral decompression, evacuation of hematoma or abscess, and clipping or removal of an aneurysm or AVM.
Patients who do require such care usually need intensive monitoring or are at greater risk for complications because of underlying cardiopulmonary dysfunction or the surgical approach used.
provides definitions of common neurosurgical terms.

A

Types of surgery - Craniotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Protection of the integrity of the CNS is a major priority of care for a patient awaiting a craniotomy. Optimal arterial oxygenation, hemodynamic stability, and cerebral perfusion are essential for maintaining adequate cerebral oxygenation. Management of seizure activity is essential for controlling metabolic needs. Detailed assessment and documentation of the patient’s preoperative neurologic status are imperative for accurate postoperative evaluation.
Preoperative teaching is necessary to prepare the patient and family for what to expect in the postoperative period. A description of the intravascular lines and intracranial catheters used during the postoperative period allows the family to focus on the patient and not be overwhelmed by masses of tubing.
All patients who undergo craniotomy require instruction to avoid activities known to provoke sudden changes in ICP.
These activities include bending, lifting, straining, and the Valsalva maneuver.
Patients undergoing transsphenoidal surgery require preparation for the sensations associated with nasal packing. Preoperative instruction in mouth breathing and avoidance of coughing, sneezing, or blowing of the nose facilitates postoperative cooperation.

A

Preop care - Craniotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Depending on the location of the lesion and the surgical route chosen, a transcranial or a transsphenoidal approach is used to open the skull.

A

Surgical considerations - Craniotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Definitive management of a postoperative neurosurgical patient varies depending on the underlying reason for the craniotomy.
During the initial postoperative period, management is usually directed toward the prevention of complications. Complications associated with a craniotomy include intracranial hypertension, surgical hemorrhage, fluid imbalance, CSF leak, and DVT.
Intracranial HTN
Cerebrospinal fluid leak
DVT
Postop nursing management

A

Postop medical management - Craniotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Postoperative cerebral edema is expected to peak 48 to 72 hours after surgery.
Close monitoring of the surgical site is important so that integrity of the incision can be maintained. Management of intracranial hypertension after craniotomy is usually accomplished through CSF drainage, patient positioning, and steroid administration.

A

Intracranial HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

after a transcranial procedure can occur in the intracranial vault and manifests as signs and symptoms of increasing ICP. Hemorrhage after a transsphenoidal craniotomy may be evident from external drainage, the patient’s complaint of persistent postnasal drip, or excessive swallowing. Loss of vision after pituitary surgery indicates an evolving hemorrhage. Postoperative hemorrhage requires surgical reexploration

A

Surgical hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

usually results from a disturbance in production or secretion of antidiuretic hormone (ADH).
The outcome is unabated renal water loss even when blood volume is low and serum osmolality is high. This condition is known as diabetes insipidus (DI). The polyuria associated with DI is often more than 200 mL/h. Urine specific gravity of 1.005 or less and elevated serum osmolality provide evidence of insufficient ADH. The loss of volume may provoke hypotension and inadequate cerebral perfusion. DI is usually self-limiting, and fluid replacement is the only required therapy. However, in some cases, it may be necessary to administer vasopressin intravenously to
control the loss of fluid.
SIADH manifests as inappropriate water retention with hyponatremia in the presence of normal renal function. Urine specific gravity is elevated, and urine osmolality is greater than serum osmolality. The dangers associated with SIADH include circulating volume overload and electrolyte imbalance, both of which may impair neurologic functioning. SIADH is usually self-limiting, with the mainstay of treatment being fluid restriction.

A

Fluid imbalance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leakage of CSF results from an opening in the subarachnoid space, as evidenced by clear fluid draining from the surgical site. When this complication occurs after transsphenoidal surgery, it is evidenced by excessive, clear drainage from the nose or persistent postnasal drip. To differentiate CSF drainage from post-operative serous drainage, a specimen is tested for glucose content.
Management of a patient with a CSF leak includes bed rest and head elevation.

A

Cerebrospinal fluid leak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

have a variety of additional risk factors, including preoperative leg weakness, longer preoperative and postoperative stay in the critical care unit, longer operative procedure time, prone positioning on frames with flexion of the hips or knees, longer time in the postanesthesia care unit, more days on bed rest, lengthy operative procedures, and delay of postoperative mobility and activity.

A

DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The nurse has a significant role in preserving adequate CPP, promoting arterial oxygenation, providing comfort and emotional support, maintaining surveillance for complications, initiating early rehabilitation, and educating the patient and family.
Frequent neurologic assessment is necessary to evaluate accomplishment of these objectives and to identify problems and quickly intervene if complications do arise. A ventriculostomy often is placed to facilitate ICP monitoring and CSF drainage.
Preserve cerebral perfusion
Promote arterial oxygenation
Provide comfort and emotional support
Initiate early rehabilitation
Educate the patient and family

A

Postop nursing management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

patient positioning, fluid management, and avoidance of post-operative vomiting and fever.
Positioning
Fluid management
Avoidance of vomiting and fever

A

Preserve cerebral perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

head of the bed should always be elevated to 30 to 45 degrees to reduce the incidence of hemorrhage, facilitate venous drainage, and control ICP.
These rules of positioning must be followed through-out all nursing activities, including linen changes and transporting the patient for diagnostic evaluation.

A

Positioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

is another important component of postcraniotomy care. Hourly monitoring of fluid intake and output facilitates early identification of fluid imbalance. Urine specific gravity must be measured if DI is suspected. Fluid restriction may be ordered as a routine measure to lessen the severity of cerebral edema or as treatment for the fluid and electrolyte imbalances associated with SIADH.

A

Fluid management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Postoperative vomiting must be avoided to prevent sharp spikes in ICP and possibly surgical hemorrhage. Antiemetics are administered as soon as nausea is apparent. Early nutrition in the patient is beneficial.
Postoperative fever may also adversely affect ICP and increase the metabolic needs of the brain. Acetaminophen is administered orally, rectally, or through a feeding tube.

A

Avoidance of vomiting and fever

21
Q

Pain management in patients after craniotomy primarily involves control of headache.
Newer approaches are being evaluated because of the side effects of opioid analgesics. Intraoperative dexmedetomidine, preoperative and postoperative gabapentin and acetaminophen, and scalp blocks are just some of the alternative pain modalities being researched.

A

Promote arterial oxygenation

22
Q

patients are at risk for infection, corneal abrasions, and injury from falls or seizures.
Infection
Corneal abrasions
Injury

A

Provide comfort and emotional support

23
Q

patients are at risk for a variety of infections, including meningitis, cerebral abscesses, bone flap infections, and subdural empyema. Care of the incision and surgical dressings is specific to the institution and the physician.
Postoperatively, infection should be suspected if the patient exhibits signs of mental status changes, headache, fever, and purulent drainage and swelling around the incision site.

A

Infection

24
Q

Routine eye care may be necessary to prevent corneal drying and ulceration. Periorbital edema interferes with normal blinking and eyelid closure, which are essential to adequate corneal lubrication. Saline drops are instilled to maintain lubrication. If the patient remains in a comatose state, covering the eyes with a polyethylene film extending over the orbits and eyebrows may be beneficial.

A

Corneal abrasions

25
Q

Protection from injury may require the use of restraint devices. The side rails of the bed must be padded to protect the patient from injury.

A

Injury

26
Q

Increased activity, including ambulation, is begun as soon as tolerated by the patient in the postoperative period.
Transfer to a general care or rehabilitation unit is usually accomplished as soon as the patient is deemed stable and free of complications.

A

Initiate early rehabilitation

27
Q

Preoperatively, the patient and family should be taught about the precipitating event necessitating the craniotomy and its expected outcome
As the patient moves toward discharge, teaching focuses on medication instructions, incisional care including the signs of infection, and the signs and symptoms of increased ICP.

A

Educate the patient and family

28
Q

The intracranial space comprises three components: (1) brain substance (80%), (2) CSF (10%), and (3) blood (10%). Under normal physiologic conditions, the mean ICP is maintained at less than 15 mm Hg.
the Monro Kellie hypothesis proposes that an increase in volume of one intracranial component must be compensated by a decrease in one or more of the other components so that total volume remains fixed. This compensation, although limited, includes displacing CSF from the intracranial vault to the lumbar cistern, increasing CSF absorption, and compressing the low-pressure venous system.
Volume-pressure curve When capable of compliance, the brain can tolerate significant increases in intracranial volume without much increase in ICP. As the ICP increases, the relationship between volume and pressure changes and small increases in volume may cause major elevations in ICP
Regardless of how fast the pressure increases, intracranial hypertension occurs when ICP is greater than 20 mm Hg.
Cerebral blood flow and autoregulation

A

Patho - Intracranial Hypertension

29
Q

The normal brain has a complex capacity to maintain constant CBF, despite wide ranges in systemic arterial pressure—an effect known as autoregulation. A mean arterial pressure of 50 to 150 mm Hg does not alter CBF when autoregulation is functioning. Outside the limits of this autoregulation, CBF becomes passively dependent on the perfusion pressure.
Factors other than arterial blood pressure that affect CBF are conditions that result in acidosis, alkalosis, and changes in metabolic rate. Conditions that cause acidosis (e.g., hypoxia, hypercapnia, ischemia) result in cerebrovascular dilation. Conditions causing alkalosis (e.g., hypocapnia) result in cerebrovascular constriction. Normally, a reduction in metabolic rate (e.g., from hypothermia or barbiturates) decreases CBF, and increases in metabolic rate (e.g., from hyperthermia) increase CBF.
Carbon dioxide retention (hypercapnia) leads to cerebral vasodilation, with increased cerebral blood volume, whereas hypocapnia leads to cerebral vasoconstriction and a reduction in cerebral blood volume.

A

Cerebral blood flow and autoregulation

30
Q

numerous signs and symptoms of increased ICP include decreased LOC, Cushing triad (bradycardia, systolic hypertension, and widening pulse pressure), diminished brainstem reflexes, papilledema, decerebrate posturing (abnormal extension), decorticate posturing (abnormal flexion), unequal pupil size, projectile vomiting, decreased pupillary reaction to light, altered breathing patterns, and headache.

A

Assessment and dx - Intracranial Hypertension

31
Q

After intracranial hypertension is documented, therapy must be prompt to prevent secondary insults most current evidence suggests that ICP generally must be treated when it exceeds 20 mm Hg.
All therapies are directed toward reducing the volume of one or more of the components (e.g., blood, brain, CSF) that lie within the intracranial vault. A major goal of therapy is to determine the cause of the elevated pressure and, if possible, to remove the cause.68 In the absence of a surgically treatable mass lesion, intracranial hypertension is treated medically. Nurses play an important role in rapid assessment and implementation of appropriate therapies for reducing ICP.
Positioning and other nursing activities
Hyperventilation
Temp control
BP control
Seizure control
CSF drainage
Hyperosmolar therapy
Control of Metabolic Demand

A

Medical and nursing management - Intracranial Hypertension

32
Q

Positioning of the patient is a significant factor in the prevention and treatment of intracranial hypertension. Head elevation has long been advocated as a conventional nursing intervention to control ICP, presumably by increasing venous return; however, this may decrease CPP. Close monitoring of ICP and CPP should be done with positioning, customizing positioning to maximize CPP and minimize ICP.
Positions that decrease venous return from the head (e.g., Trendelenburg, prone, extreme flexion of the hips, and angulation of the neck) must be avoided if possible. If changes to positions such as Trendelenburg are necessary to provide adequate pulmonary care, critical care nurses must closely monitor ICP and vital signs.

A

Positioning and other nursing activities

33
Q

Controlled hyperventilation has been an important adjunct of therapy for patients with increased ICP. The rationale employed in hyperventilation is that if PaCO2 can be reduced from its normal level of 35 to 40 mm Hg to a range of 25 to 30 mm Hg in a patient with intracranial hypertension, vasoconstriction of cerebral arteries, reduction of CBF, and increased venous return will result.
The use of pulse oximetry has led to greater awareness of the circumstances, such as pain and anxiety, that can cause oxygen desaturation and elevate ICP

A

Hyperventilation

34
Q

This fact is significant because as the cerebral metabolic rate increases, blood flow to the brain must increase to meet the tissue demands. To avoid the increase in blood volume associated with an increased cerebral metabolic rate, nurses must prevent hyperthermia in a patient with a brain injury. Antipyretics and cooling devices must be used

A

Temp control

35
Q

Maintenance of arterial blood pressure in the high-normal range is essential in patients with brain injury. Inadequate perfusion pressure decreases the supply of nutrients and oxygen requirements for cerebral metabolic needs. However, a blood pressure that is too high increases cerebral blood volume and may increase ICP.
To reduce this vasodilating effect, concurrent treatment with beta-blockers (e.g., metoprolol, labetalol) may be beneficial.

A

BP control

36
Q

Because of the risk of a secondary ischemic insult associated with seizures, many physicians prescribe anticonvulsant medications prophylactically.
Seizures cause metabolic requirements to increase, which results in elevation of CBF, cerebral blood volume, and ICP, even in paralyzed patients.
Fast-acting, short-duration agents such as lorazepam may be indicated for breakthrough seizures until therapeutic medication levels can be achieved.

A

Seizure control

37
Q

For intracranial hypertension may be used with other treatment modalities accomplished by the insertion of a pliable catheter into the anterior horn of the lateral ventricle (ventriculostomy), preferably on the nondominant side. This drainage can help support the patient through periods of cerebral edema by controlling spikes in ICP. A major advantage of ventriculostomy is its dual role as a monitoring device and a treatment modality.75 Care should be taken to avoid infection. However, cleansing ointment such as bacitracin or povidone is not recommended.

A

CSF drainage

38
Q

Osmotic diuretics and hypertonic saline have also been used to reduce increased ICP.
The most widely used osmotic diuretic is mannitol, a large-molecule agent that is retained almost entirely in the extracellular compartment and has little of the rebound effect observed with other osmotic diuretics. Administration of mannitol increases CBF and induces cerebral vasoconstriction as part of the brain’s autoregulatory response to keep blood flow constant.
Careful attention must be paid to body weight and fluid and electrolyte stability. Serum osmolality must be kept between 300 and 320 mOsm/L. Hypernatremia and hypokalemia often are associated with repeated administration of osmotic agents. Central venous pressure readings must be monitored to prevent hypovolemia. Smaller doses of mannitol simplify fluid and electrolyte management, and their use is encouraged whenever possible.
Hypertonic 3% saline can also be used to treat increased ICP. Hypertonic saline has been found to be equally as effective as mannitol for reducing increased ICP. Adverse effects include electrolyte abnormalities, hypotension, pulmonary edema, acute kidney injury, hemolysis, central pontine myelinolysis, coagulopathy, and dysrhythmias.

A

Hyperosmolar therapy

39
Q

Any treatment modality that increases the incidence of noxious stimulation to the patient carries with it the potential for increasing ICP.
Agents used to reduce metabolic demands include the use of benzodiazepines such as midazolam and lorazepam, intravenous sedative-hypnotics such as propofol, opioids such as fentanyl and morphine, and neuromuscular blocking agents such as vecuronium and atracurium. These agents may be administered separately or in combination via continuous drip or as an intravenous bolus on an as-needed basis.
The preferred treatment regimen begins with the administration of benzodiazepines for sedation and opioids for analgesia.
If these agents fail to blunt the patient’s response to noxious stimuli, propofol or a neuromuscular blocking agent is added.
The use of neuromuscular blocking agents with-out sedation is not recommended, because these agents can cause skeletal muscle paralysis and because they have no analgesic effect and do not adequately protect the patient from pain and the physiologic responses that can occur from pain-producing procedures. If these agents fail to control ICP, barbiturate therapy is considered.
Barbituate therapy

A

Control of Metabolic Demand

40
Q

Barbiturate therapy is a treatment protocol developed for the management of uncontrolled intracranial hypertension that has not responded to the conventional treatments previously described. The most commonly used medica-
tion in high-dose barbiturate therapy is pentobarbital. The goal is a reduction of ICP to 15 to 20 mm Hg while a mean arterial pressure of 70 to 80 mm Hg is maintained. Patients are maintained on high-dose barbiturate therapy until ICP has been controlled with-in the normal range for 24 hours. Barbiturates must never be stopped abruptly; they are tapered slowly over approximately 4 days. Complications of high-dose barbiturate therapy can be disastrous unless a specific and organized approach is used. The most common complications are hypotension, hypothermia, and myocardial depression. If any complications occur and are allowed to persist unchecked, they may cause secondary insults to an already damaged brain.

A

Barbituate therapy

41
Q

The goal of neurologic evaluation, ICP monitoring, and treatment of increased ICP is to prevent herniation. Herniation of intracerebral contents results in the shifting of tissue from one compartment of the brain to another and places pressure on cerebral vessels and vital function centers of the brain. If unchecked, herniation rapidly causes death as a result of the cessation of CBF and respirations.

A

Herniation syndromes

42
Q

Dosage:
Loading dose: 10-20 mg/kg IV
Maintenance dose: 100 mg q6 8 h IV
Action:
Prevents influx of sodium at cell membrane
Special considerations:
Infuse phenytoin no faster than 50 mg/min; administer with normal saline only because it precipitates with other solutions
Monitor serum levels closely; therapeutic level is 10-20 mg/L (if hypoalbuminuria, monitor free phenytoin serum levels: therapeutic level of 0.1 0.2 mg/L)

A

Phenytoin (Dilantin) - Anticonvulsants

43
Q

Dosage
Loading dose: 15-20 mg/kg IV
Maintenance dose: 4-6 mg/kg/24 h IV
Action
Prevents influx of sodium at cell membrane
Special considerations
Monitor serum levels closely; therapeutic level is 10 20 mg/L
Dosage, concentration, and infusion rate of fosphenytoin expressed as FE

A

Fosphenytoin (Cerebyx) - Anticonvulsants

44
Q

Dosage
Loading dose: 6-8 mg/kg IV
Maintenance dose: 1-3 mg/kg/24 h IV
Action
Produces CNS depression and reduces spread of epileptic focus
Special considerations
May depress cardiac and respiratory function
Administer phenobarbital at a rate of 60 mg/min; monitor serum level closely; therapeutic level is 15 40 mcg/mL

A

Phenobarbital - Barbituates

45
Q

Dosage
Loading dose: 3-10 mg/kg over 30 min
Maintenance dose: 0.5-3 mg/kg/h IV
Action
Induces barbiturate coma
Special considerations
Monitor serum level of pentobarbital closely; therapeutic level for coma is 15-40 mg/L

A

Pentobarbital - Barbituates

46
Q

Dosage
1-2 g/kg IV
Action
Treats cerebral edema by pulling fluid from extravascular space into intravascular space; requires intact blood brain barrier
Special considerations
Side effects include hypovolemia and increased serum osmolality
Monitor serum osmolality and notify physician if .310 mOsm/L
Warm and shake before administering to ensure crystals are dissolved

A

Mannitol - Osmotic diuretics

47
Q

Dosage
60 mg q4h NG or PO for 21 days
Action
Decreases cerebral vasospasm
Special considerations
Side effects include hypotension, palpitations, headache, and dizziness
Monitor blood pressure frequently when implementing therapy

A

Nimodipine (Nimotop) - Calcium Channel Blockers

48
Q

Dosage
50-100 mg IV or 2 mL of 4% solution
Action
Blunts effects of tracheal stimulation on intracranial pressure
Special considerations
Must be administered not longer than 5 min before suctioning

A

Lidocaine - Local Anesthetics

49
Q

Dosage
0.9 mg/kg total, with 10% of dose administered as IV bolus over 1 min and 90% of dose administered as continuous IV infusion over 1 h
Action
Converts plasminogen to plasmin to dissolve clot
Special considerations
Treatment must start within 4.5 h of onset of symptoms
Do not exceed 90 mg
Do not use anticoagulants during the first 24 h
Monitor patient for bleeding

A

tPA - Fibrinolytics